Isozeaxanthin

3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(3-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-ol

GYZWNQLEQAGWGD-DKLMTRRASA-N CHEBI:176095 0 Reactome links 2 studies

Metabolite details

Identifier: GYZWNQLEQAGWGD-DKLMTRRASA-N
InChI Key: GYZWNQLEQAGWGD-DKLMTRRASA-N
IUPAC name: 3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(3-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-ol
Preferred name: Isozeaxanthin
INN name: —
Synonym: —
ChEBI: CHEBI:176095

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)
Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

36_week_vs_104_week
G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h